11. 重症筋無力症 Myasthenia gravis Clinical trials / Disease details
臨床試験数 : 332 / 薬物数 : 234 - (DrugBank : 81) / 標的遺伝子数 : 45 - 標的パスウェイ数 : 127
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04965987 (ClinicalTrials.gov) | October 2021 | 10/6/2021 | Oxaloacetate in Myasthenia Gravis | A Phase I, Double-Blind, Pilot Study of Oxaloacetate in Myasthenia Gravis | Myasthenia Gravis | Drug: Oxaloacetate;Drug: Placebo | University of Kansas Medical Center | Terra Biological LLC | Not yet recruiting | 18 Years | N/A | All | 12 | Phase 1 | United States |